Bellerophon Therapeutics
BLPH
#10119
Rank
A$0.71 M
Marketcap
$0.05830
Share price
2.70%
Change (1 day)
27.47%
Change (1 year)

Earnings for Bellerophon Therapeutics (BLPH)

Earnings in 2023 (TTM): -A$16.6 Million

According to Bellerophon Therapeutics 's latest financial reports the company's current earnings are A$5.64 Million. In 2022 the company made an earning of -A$34.35 Million a decrease over its 2021 earnings that were of -A$30.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Bellerophon Therapeutics from 2014 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$16.6 Million-51.69%
2022 -A$34.35 Million11.03%
2021 -A$30.94 Million-24.22%
2020 -A$40.82 Million52.25%
2019 -A$26.81 Million-37.33%
2018 -A$42.78 Million13.34%
2017 -A$37.75 Million3.54%
2016 -A$36.46 Million-48.98%
2015 -A$71.45 Million-22.15%
2014 -A$91.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.12 Billion 579.66%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$80.71 Million 376.66%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.39 B-61,522.75%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.88 B-5,299.97%๐Ÿ‡บ๐Ÿ‡ธ USA